Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Coordination and Support Action · Running

WANETAM-4 West African Network of Excellence for TB, AIDS and Malaria

Coordinator
European & Developing Countries Clinical Trials Partnership, Netherlands
Runs
1 July 2026 to 30 June 2031
Status
Running
EU funding
€12.8m
Total cost
—
Partners
30 organisations in 14 countries
Type
Coordination and Support Action
Grant agreement
101248831

What the project is doing

In the project's own words, from its summary on CORDIS.

The West Africa Networks of Excellence for TB, AIDS, and Malaria (WANETAM) has developed over 3 previous funding cycles for research capacity development in West Africa. The WANETAM-4 proposal will build upon the achievements of the previous cycles to further enhance expertise in clinical research and stronger linkages to global partners and national public Health Institutions (PHIs), with a vision to attain sustainable capacity for conducting clinical research and safeguarding against epidemics in the region.

WANETAM-4 will implement its activities through 8 Work Programs, including TB, Malaria, HIV, Special Collaborative Training on Epidemic Preparedness and Surveillance (SCTEPS), Cross-Cutting Training (C-C), Clinical Trial Preparedness, Scientific Program Management, and Dissemination and Exploitation. The TB program aims to unravel the burden and determinants of TB multimorbidity and its impact on treatment outcome, whilst building expertise at partner institutions including PHIs.

It will also collaborate with the LSHTM TB Centre, QURE.AI and IAVI to further strengthen capacity for transdisciplinary research on TB. The Malaria program will build capacity to support PHIs to achieve malaria pre-elimination and elimination in the region. It will address disparities in capacity for genomic surveillance, clinical trials, entomology, epidemiology and modelling for African ownership innovation and context-specific interventions for elimination.

The HIV program will aim to map out challenges in rapid early childhood diagnosis, to improve data on drug-resistance mutations, and collaborate with the Global HIV vaccine Enterprise of the IAS for capacity training. The lessons learnt from COVID-19 impelled the development of the SCTEPS program, in which training in epidemic preparedness will be in synergy with regional programs and the Scientific Program Management will coordinate with the C-C training program to achieve research expertise.

Topics

Who is involved

OrganisationCityCountryRole
European & Developing Countries Clinical Trials PartnershipDen HaagNetherlandsCoordinator
Instituut Voor Tropische GeneeskundeAntwerpenBelgiumParticipant
Centre National De Recherche Scientifique Et Technologique*institut De Recherche En Sciences De La SanteOuagadougouBurkina FasoParticipant
Groupe De Recherche Action En Sante SARLOuagadougouBurkina FasoParticipant
Institut National De Sante PubliqueOuagadougouBurkina FasoParticipant
Fondation Pour La Recherche Scientifique (fors)CotonouBJParticipant
Universite D'abomey-CalaviAbomey CalaviBJParticipant
European Vaccine Initiative eVHeidelbergGermanyParticipant
Forschungszentrum Borstel Leibniz LungenzentrumBorstelGermanyParticipant
Institut De Recherche Pour Le DeveloppementMarseilleFranceParticipant
University of GhanaAccraGhanaParticipant
L'Hopital National DonkaConakryGNParticipant
Ministere De La Sante Et Lhygiene PubliqueKaloumGNParticipant
Instituto Nacional De Saude PublicaBissauGWParticipant
Universite Des Sciences Des Techniques Et Des Technologies De BamakoBamakoMLParticipant
Ahmadu Bello UniversityZariaNGParticipant
College of MedicineIbadanNGParticipant
Institute of Human Virology Nigeria LtdgteAbujaNGParticipant
Jos University Teaching HospitalJosNGParticipant
Nigerian Institute of Medical ResearchLagosNGParticipant
West African Research and Innovation Management Association Warima LtdIbadanNGParticipant
Stichting International Aids Vaccine Initiative the NetherlandsAmsterdamNetherlandsParticipant
Instituto Piaget Coop Para O Desenvimento Humano Integral Ecologico CrlCanelas Vila Nova De GaiaPortugalParticipant
Universidade Nova De LisboaLisboaPortugalParticipant
Institut Pasteur De DakarDakarSNParticipant
Reseau Africain De Recherche En SanteDakarSNParticipant
Universite Cheikh Anta Diop De DakarDakar FannSNParticipant
London School of Hygiene and Tropical Medicine Royal CharterLondonUnited KingdomParticipant
Malaria ConsortiumLondonUnited KingdomParticipant
Qure.aiBirminghamUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI